Davis Blaine has filed 10 insider transactions across 1 company since November 2023.
Most recent transaction: a sale of 10591 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 06, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | S | Common Stock | 10591 | $6.82 | 121,220.0000 | 26,003,606 | 8.03% | 0.04% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | A | Employee Stock Option (right to buy) | 109000 | $0.00 | 109,000.0000 | 26,003,606 | 9999.99% | 0.42% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | A | Common Stock | 37000 | $0.00 | 131,811.0000 | 26,003,606 | 39.03% | 0.14% |
| Jan. 3, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | S | Common Stock | 3961 | $16.72 | 98,839.0000 | 25,767,369 | 3.85% | 0.02% |
| Jan. 6, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | S | Common Stock | 4028 | $16.83 | 94,811.0000 | 25,767,369 | 4.08% | 0.02% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | A | Employee Stock Option (right to buy) | 64600 | $0.00 | 168,266.0000 | 25,767,369 | 62.32% | 0.25% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | A | Common Stock | 22000 | $0.00 | 102,800.0000 | 25,767,369 | 27.23% | 0.09% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | A | Employee Stock Option (right to buy) | 3110000 | $0.00 | 3,110,000.0000 | 5,397,597 | 9999.99% | 57.62% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | A | Common Stock | 2424000 | $0.00 | 2,424,000.0000 | 5,397,597 | 9999.99% | 44.91% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Davis Blaine | Chief Financial Officer | D | Employee Stock Option (right to buy) | 1250000 | $0.79 | 0.0000 | 5,101,459 | 100.00% | 24.50% |